Literature DB >> 7480384

Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity.

F Jenck1, J L Moreau, J R Martin.   

Abstract

Neurosurgical stimulation of the dorsal periaqueductal gray (dPAG) matter in man induces acute signs of autonomic arousal and feelings of subjective anxiety; those signs have phenomenological similarity with the symptom profile characterizing a panic attack. Animals undergoing dPAG stimulation show comparable physical signs of autonomic activation and sudden fear-suggestive behavioral reactions that can be shaped into operant self-interruption behavior. Drugs known to acutely reduce (alprazolam, clonazepam) or precipitate (yohimbine, caffeine) panic attacks in patients were found to acutely and dose-dependently reduce or enhance, respectively, aversion induced by dPAG stimulation in rats. When considered as an animal model of panic anxiety, the dPAG model simultaneously meets criteria of face validity (symptomatic homology) and predictive validity (pharmacological homology under short-term treatment); aspects of its construct validity (theoretical rationale supporting the model) are discussed. It is suggested that dPAG stimulation-induced aversion may represent a model of some aspects of panic disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480384     DOI: 10.1016/0165-1781(95)02673-k

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  30 in total

1.  Periaqueductal gray matter modulates the hypercapnic ventilatory response.

Authors:  Luana T Lopes; Luis G A Patrone; Kênia C Bícego; Norberto C Coimbra; Luciane H Gargaglioni
Journal:  Pflugers Arch       Date:  2012-06-05       Impact factor: 3.657

2.  Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.

Authors:  Plínio C Casarotto; Ana Luisa B Terzian; Daniele C Aguiar; Hélio Zangrossi; Francisco S Guimarães; Carsten T Wotjak; Fabrício A Moreira
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

Review 3.  Animal models of anxiety disorders.

Authors:  Joachim D K Uys; Dan J Stein; Willie M U Daniels; Brian H Harvey
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

Review 4.  The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.

Authors:  Evan D Paul; Philip L Johnson; Anantha Shekhar; Christopher A Lowry
Journal:  Neurosci Biobehav Rev       Date:  2014-03-21       Impact factor: 8.989

5.  Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray.

Authors:  Valquíria Camin de Bortoli; Regina Lúcia Nogueira; Hélio Zangrossi
Journal:  Psychopharmacology (Berl)       Date:  2005-10-29       Impact factor: 4.530

6.  Serotonin-2A receptor regulation of panic-like behavior in the rat dorsal periaqueductal gray matter: the role of GABA.

Authors:  Thatiane de Oliveira Sergio; Valquiria Camin de Bortoli; Helio Zangrossi
Journal:  Psychopharmacology (Berl)       Date:  2011-06-10       Impact factor: 4.530

7.  Neural correlates of predictable and unpredictable threat in internalizing psychopathology.

Authors:  Milena Radoman; K Luan Phan; Stephanie M Gorka
Journal:  Neurosci Lett       Date:  2019-02-27       Impact factor: 3.046

8.  Benzodiazepine receptor and serotonin 2A receptor modulate the aversive-like effects of nitric oxide in the dorsolateral periaqueductal gray of rats.

Authors:  Fabrício Araújo Moreira; Francisco Silveira Guimarães
Journal:  Psychopharmacology (Berl)       Date:  2004-07-22       Impact factor: 4.530

9.  Alprazolam potentiates the antiaversive effect induced by the activation of 5-HT(1A) and 5-HT (2A) receptors in the rat dorsal periaqueductal gray.

Authors:  Valquíria Camin de Bortoli; Regina Lúcia Nogueira; Hélio Zangrossi
Journal:  Psychopharmacology (Berl)       Date:  2008-04-30       Impact factor: 4.530

10.  Development × environment interactions control tph2 mRNA expression.

Authors:  J L Lukkes; J M Kopelman; N C Donner; M W Hale; C A Lowry
Journal:  Neuroscience       Date:  2013-02-09       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.